Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295185252> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4295185252 endingPage "746" @default.
- W4295185252 startingPage "737" @default.
- W4295185252 abstract "In Japan, eicosapentaenoic acid ethyl ester (EPA-E) is administered twice-daily or three-times-daily for dyslipidemia. We have developed MND-2119, a novel self-emulsifying formulation of highly purified EPA-E which can be administered once-daily.The objective of this study was to investigate the safety and efficacy of long-term administration of MND-2119 in hypertriglyceridemia patients.In this multicenter, 52-week, open-label study, patients with high triglyceride (TG) (TG levels between ≥ 150 and < 500 mg/dL) undergoing lifestyle modification were randomized to MND-2119 2 g/day (n=61) or MND-2119 4 g/day (n=61).The incidence of adverse events in MND-2119 2 g/day and MND-2119 4 g/day was 70.5% and 62.3%, respectively, and the incidence of adverse drug reactions was 9.8% and 8.2%, respectively. There were no notable problems in the safety assessments of both treatment groups. By Week 4, TG levels had decreased from baseline in both groups, and the TG reducing effect continued up to Week 52 (mean percentage change from baseline in TG at Week 52 [two-sided 95% confidence interval]: MND-2119 2 g/day: -16.71% [-26.61, -6.81], MND-2119 4 g/day: -21.01% [-27.86, -14.16]). In both groups, plasma EPA concentration at Week 4 was maintained up until Week 52 and the plasma EPA concentration at Week 52 was 200.5 ± 54.7 μg/mL in MND-2119 2 g/day and 308.6 ± 98.6 μg/mL in MND-2119 4 g/day.Long-term administration of MND-2119 was not associated with any safety-related problems. TG levels decreased by Week 4, and the TG reducing effect continued up to Week 52." @default.
- W4295185252 created "2022-09-11" @default.
- W4295185252 creator A5039778597 @default.
- W4295185252 creator A5067309135 @default.
- W4295185252 creator A5074146540 @default.
- W4295185252 date "2022-09-01" @default.
- W4295185252 modified "2023-09-25" @default.
- W4295185252 title "Long-term safety and efficacy of MND-2119 (self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester) in patients with hypertriglyceridemia: Results from a multicenter, 52-week, open-label study" @default.
- W4295185252 cites W1967873252 @default.
- W4295185252 cites W1977704640 @default.
- W4295185252 cites W1995350891 @default.
- W4295185252 cites W2125439260 @default.
- W4295185252 cites W2142347023 @default.
- W4295185252 cites W2614647096 @default.
- W4295185252 cites W2777757515 @default.
- W4295185252 cites W2899669642 @default.
- W4295185252 cites W2902161659 @default.
- W4295185252 cites W2925924778 @default.
- W4295185252 cites W3021659692 @default.
- W4295185252 cites W65377277 @default.
- W4295185252 doi "https://doi.org/10.1016/j.jacl.2022.09.002" @default.
- W4295185252 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36202740" @default.
- W4295185252 hasPublicationYear "2022" @default.
- W4295185252 type Work @default.
- W4295185252 citedByCount "1" @default.
- W4295185252 countsByYear W42951852522023 @default.
- W4295185252 crossrefType "journal-article" @default.
- W4295185252 hasAuthorship W4295185252A5039778597 @default.
- W4295185252 hasAuthorship W4295185252A5067309135 @default.
- W4295185252 hasAuthorship W4295185252A5074146540 @default.
- W4295185252 hasConcept C120665830 @default.
- W4295185252 hasConcept C121332964 @default.
- W4295185252 hasConcept C126322002 @default.
- W4295185252 hasConcept C185592680 @default.
- W4295185252 hasConcept C19038510 @default.
- W4295185252 hasConcept C197934379 @default.
- W4295185252 hasConcept C2776091944 @default.
- W4295185252 hasConcept C2776919658 @default.
- W4295185252 hasConcept C2778096610 @default.
- W4295185252 hasConcept C2778163477 @default.
- W4295185252 hasConcept C2778913445 @default.
- W4295185252 hasConcept C2779134260 @default.
- W4295185252 hasConcept C543025807 @default.
- W4295185252 hasConcept C55493867 @default.
- W4295185252 hasConcept C61511704 @default.
- W4295185252 hasConcept C71924100 @default.
- W4295185252 hasConcept C90924648 @default.
- W4295185252 hasConceptScore W4295185252C120665830 @default.
- W4295185252 hasConceptScore W4295185252C121332964 @default.
- W4295185252 hasConceptScore W4295185252C126322002 @default.
- W4295185252 hasConceptScore W4295185252C185592680 @default.
- W4295185252 hasConceptScore W4295185252C19038510 @default.
- W4295185252 hasConceptScore W4295185252C197934379 @default.
- W4295185252 hasConceptScore W4295185252C2776091944 @default.
- W4295185252 hasConceptScore W4295185252C2776919658 @default.
- W4295185252 hasConceptScore W4295185252C2778096610 @default.
- W4295185252 hasConceptScore W4295185252C2778163477 @default.
- W4295185252 hasConceptScore W4295185252C2778913445 @default.
- W4295185252 hasConceptScore W4295185252C2779134260 @default.
- W4295185252 hasConceptScore W4295185252C543025807 @default.
- W4295185252 hasConceptScore W4295185252C55493867 @default.
- W4295185252 hasConceptScore W4295185252C61511704 @default.
- W4295185252 hasConceptScore W4295185252C71924100 @default.
- W4295185252 hasConceptScore W4295185252C90924648 @default.
- W4295185252 hasIssue "5" @default.
- W4295185252 hasLocation W42951852521 @default.
- W4295185252 hasLocation W42951852522 @default.
- W4295185252 hasOpenAccess W4295185252 @default.
- W4295185252 hasPrimaryLocation W42951852521 @default.
- W4295185252 hasRelatedWork W1070322143 @default.
- W4295185252 hasRelatedWork W1967873252 @default.
- W4295185252 hasRelatedWork W1994077120 @default.
- W4295185252 hasRelatedWork W2005022918 @default.
- W4295185252 hasRelatedWork W2074147578 @default.
- W4295185252 hasRelatedWork W2098362024 @default.
- W4295185252 hasRelatedWork W2391091442 @default.
- W4295185252 hasRelatedWork W2415241284 @default.
- W4295185252 hasRelatedWork W2899669642 @default.
- W4295185252 hasRelatedWork W2962945803 @default.
- W4295185252 hasVolume "16" @default.
- W4295185252 isParatext "false" @default.
- W4295185252 isRetracted "false" @default.
- W4295185252 workType "article" @default.